Chemo-Pharma [CPL] vs Karuturi Global [KGL] Detailed Stock Comparison

Chemo-Pharma Laboratories Inc.

BSE
Loading...

Karuturi Global Limited

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Chemo-Pharma Laboratories Inc. wins in 7 metrics, Karuturi Global Limited wins in 10 metrics, with 0 ties. Karuturi Global Limited appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Chemo-Pharma Laboratories Inc. Karuturi Global Limited Better
P/E Ratio (TTM) 13.22 1.32 Karuturi Global Limited
Price-to-Book Ratio 2.69 0.01 Karuturi Global Limited
Debt-to-Equity Ratio 48.02 0.02 Karuturi Global Limited
PEG Ratio 0.42 -0.02 Chemo-Pharma Laboratories Inc.
EV/EBITDA 13.60 5.21 Karuturi Global Limited
Profit Margin (TTM) 6.53% 42.62% Karuturi Global Limited
Operating Margin (TTM) 11.52% 24.63% Karuturi Global Limited
EBITDA Margin (TTM) 11.52% 24.63% Karuturi Global Limited
Return on Equity 20.97% 2.30% Chemo-Pharma Laboratories Inc.
Return on Assets (TTM) 11.26% 1.77% Chemo-Pharma Laboratories Inc.
Free Cash Flow (TTM) $41.66M N/A N/A
1-Year Return -5.34% 0.00% Karuturi Global Limited
Price-to-Sales Ratio (TTM) 1.31 0.13 Karuturi Global Limited
Enterprise Value $5.40B $4.57B Chemo-Pharma Laboratories Inc.
EV/Revenue Ratio 1.52 1.99 Chemo-Pharma Laboratories Inc.
Gross Profit Margin (TTM) 24.93% 47.66% Karuturi Global Limited
Revenue per Share (TTM) $62 $2 Chemo-Pharma Laboratories Inc.
Earnings per Share (Diluted) $5.81 $0.35 Chemo-Pharma Laboratories Inc.
Beta (Stock Volatility) 0.28 N/A N/A

Chemo-Pharma Laboratories Inc. vs Karuturi Global Limited Stock Performance Analysis

Loading Price Chart...

CPL
KGL

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Chemo-Pharma Laboratories Inc.0.43%-0.20%-9.72%10.04%-11.06%-12.31%
Karuturi Global Limited0.00%0.00%0.00%0.00%0.00%0.00%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Chemo-Pharma Laboratories Inc.-5.34%232.23%82.57%325.71%1,271.09%1,271.09%
Karuturi Global Limited0.00%0.00%0.00%-88.24%-98.35%-98.87%

Performance & Financial Health Analysis: Chemo-Pharma Laboratories Inc. vs Karuturi Global Limited

MetricCPLKGL
Market Information
Market Cap i₹4.62B₹299.51M
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i97,700N/A
90 Day Avg. Volume i68,661N/A
Last Close₹70.50₹0.20
52 Week Range₹52.67 - ₹87.75₹0.20 - ₹0.20
% from 52W High-19.66%0.00%
All-Time High₹128.00 (Jan 06, 2025)₹44.20 (Jan 07, 2008)
% from All-Time High-44.92%-99.55%
Growth Metrics
Quarterly Revenue Growth0.40%0.04%
Quarterly Earnings Growth0.41%0.02%
Financial Health
Profit Margin (TTM) i0.07%0.43%
Operating Margin (TTM) i0.12%0.25%
Return on Equity (TTM) i0.21%0.02%
Debt to Equity (MRQ) i48.020.02
Cash & Liquidity
Book Value per Share (MRQ)₹28.58₹16.51
Cash per Share (MRQ)₹0.05N/A
Operating Cash Flow (TTM) i₹277.99M₹800.73M
Levered Free Cash Flow (TTM) i₹313.23M₹519.31M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i₹0.00₹0.00

Valuation & Enterprise Metrics Analysis: Chemo-Pharma Laboratories Inc. vs Karuturi Global Limited

MetricCPL (Apr 26, 2026)KGL (Oct 22, 2025)
Price Ratios
P/E Ratio (TTM) i13.221.32
Forward P/E iN/AN/A
PEG Ratio i0.42-0.02
Price to Sales (TTM) i1.310.13
Price to Book (MRQ) i2.690.01
Market Capitalization
Market Capitalization i₹4.62B₹299.51M
Enterprise Value i₹5.40B₹4.57B
Enterprise Value Metrics
Enterprise to Revenue i1.521.99
Enterprise to EBITDA i13.605.21
Risk & Other Metrics
Beta i0.28N/A
Book Value per Share (MRQ) i₹28.58₹16.51

Financial Statements Comparison: Chemo-Pharma Laboratories Inc. vs Karuturi Global Limited

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCPL (2025)KGL
Revenue/Sales i2.85BN/A
Cost of Goods Sold i2.07BN/A
COGS % of Revenue i72.6%-
Gross Profit i778.98MN/A
Gross Margin i27.4%-
Research & Development iN/AN/A
Operating Income (EBIT) i300.69MN/A
Operating Margin i10.6%-
EBITDA i353.29MN/A
EBITDA Margin i12.4%-
Pre-Tax Income i392.47MN/A
Pre-Tax Income % of Revenue i13.8%-
Income Tax i79.24MN/A
Income Tax % of Revenue i2.8%-
Net Income (Profit) i313.23MN/A
Profit Margin i11.0%-

Balance Sheet & Liquidity Metrics

MetricCPL (2025)KGL
Cash & Equivalents i12.05MN/A
Total Current Assets i2.51BN/A
Total Current Assets % of Revenue i88.1%-
Total Current Liabilities i1.17BN/A
Total Current Liabilities % of Revenue i41.2%-
Long-Term Debt i109.50MN/A
Long-Term Debt % of Revenue i3.8%-
Total Shareholders Equity i1.49BN/A
Retained Earnings i1.08BN/A
Retained Earnings % of Revenue i37.9%-
Property, Plant & Equipment i48.61MN/A

Cash Flow Statement Comparison

MetricCPL (2025)KGL
Operating Cash Flow i277.99MN/A
Operating Cash Flow % of Revenue i9.8%-
Capital Expenditures i-47.82MN/A
Free Cash Flow i41.66MN/A
FCF Margin i1.5%-
Debt Repayment i-359.80MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricCPLKGL
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i60.18M1.50B
Float Shares i17.41MN/A
% Held by Insiders i69.98%N/A
% Held by Institutions i0.00%N/A
% Held by Public i30.02%N/A

Dividend Analysis & Yield Comparison: Chemo-Pharma Laboratories Inc. vs Karuturi Global Limited

MetricCPLKGL
Last 12-Month Dividend i₹0.00₹0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i₹0.00₹0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i₹0.00₹0.00
Ex-Dividend DateN/AN/A